---
layout: post
title: "FDA Rare Disease Innovation Hub Future Programming; Request for Comments"
date: 2026-02-04 21:14:55 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2026-01903
original_published: 2026-01-30 00:00:00 +0000
significance: 8.00
---

# FDA Rare Disease Innovation Hub Future Programming; Request for Comments

**Published:** February 04, 2026 21:14 UTC
**Source:** Federal Register
**Original Published:** January 30, 2026 00:00 UTC
**Document Number:** 2026-01903

## Summary

The Food and Drug Administration (FDA or the Agency) is announcing the following request for comments for a future public workshop series entitled "Rare disease Innovation, Science, and Exploration (RISE) Workshop." The purpose of the public workshops is to focus on challenges that are common to multiple diseases or a class of diseases, and for which evolving science offers innovative solutions. The workshops will primarily focus on cross-cutting or common issues and will not be focused on any specific product under review by the Agency. The Agency further welcomes comments that highlight general rare disease-related issues of potential interest for the FDA Rare Disease Innovation Hub (Hub) to inform its future activities.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2026/01/30/2026-01903/fda-rare-disease-innovation-hub-future-programming-request-for-comments)
- API: https://www.federalregister.gov/api/v1/documents/2026-01903

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
